Hamad et al., 2024a
In this context, GLP-1 receptor agonists represent one of the most promising pharmacological classes, particularly if challenges related to cost, equitable access, reimbursement policy, and supply constraints are addressed
20:5n-3 elongates to 22:5n-3, a precursor to hydroxy fatty acids, and finally to 22:6n-3, which gives rise to F4 isoprostanes
Shared dysregulated pathways lead to Parkinsons disease and diabetes
The medications effectiveness varies based on individual factors, including metabolic characteristics, baseline BMI, dietary habits, and consistency
Henkel ND, Wu X, ODonovan SM, Devine EA, Jiron JM, Rowland LM, et al